Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A

Ling Liu,1 Jirong Lu,1 Barrett W Allan,2 Ying Tang,2 Jonathan Tetreault,1 Chi-kin Chow,1 Barbra Barmettler,2 James Nelson,2 Holly Bina,1 Lihua Huang,3 Victor J Wroblewski,4 Kristine Kikly1 1Biotechnology Discovery Research, Indianapolis, IN, 2Applied Molecular Evolution, Lilly Biotechnology...

Full description

Bibliographic Details
Main Authors: Liu L, Lu J, Allan BW, Tang Y, Tetreault J, Chow C, Barmettler B, Nelson J, Bina H, Huang L, Wroblewski VJ, Kikly K
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Journal of Inflammation Research
Subjects:
ixekizumab
IL-17A monoclonal antibody
anti-IL-17A
Online Access:https://www.dovepress.com/generation-and-characterization-of-ixekizumab-a-humanized-monoclonal-a-peer-reviewed-article-JIR

Internet

https://www.dovepress.com/generation-and-characterization-of-ixekizumab-a-humanized-monoclonal-a-peer-reviewed-article-JIR

Similar Items